These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units. Roos JF, Bulitta J, Lipman J, Kirkpatrick CM. J Antimicrob Chemother; 2006 Nov; 58(5):987-93. PubMed ID: 16943209 [Abstract] [Full Text] [Related]
10. Pharmacokinetics of cefepime and comparison with those of ceftiofur in horses. Guglick MA, MacAllister CG, Clarke CR, Pollet R, Hague C, Clarke JM. Am J Vet Res; 1998 Apr; 59(4):458-63. PubMed ID: 9563631 [Abstract] [Full Text] [Related]
12. The pharmacokinetic profile of a new generation of parenteral cephalosporin. Rybak M. Am J Med; 1996 Jun 24; 100(6A):39S-44S. PubMed ID: 8678096 [Abstract] [Full Text] [Related]
13. Intravitreal penetration of cefepime after systemic administration to humans. Aras C, Ozdamar A, Ozturk R, Karacorlu M, Ozkan S. Ophthalmologica; 2002 Jun 24; 216(4):261-4. PubMed ID: 12207129 [Abstract] [Full Text] [Related]
16. Multiple dose pharmacokinetics, safety, and effects on faecal microflora, of cefepime in healthy volunteers. Bächer K, Schaeffer M, Lode H, Nord CE, Borner K, Koeppe P. J Antimicrob Chemother; 1992 Sep 24; 30(3):365-75. PubMed ID: 1452502 [Abstract] [Full Text] [Related]
17. The pharmacokinetics, safety, and tolerance of cefepime administered as an intravenous bolus or as a rapid infusion. Garrelts JC, Wagner DJ. Ann Pharmacother; 1999 Dec 24; 33(12):1258-61. PubMed ID: 10630824 [Abstract] [Full Text] [Related]
18. Continuous versus intermittent infusion of cefepime in neurosurgical patients with post-operative intracranial infections. Huang H, Huang S, Zhu P, Xi X. Int J Antimicrob Agents; 2014 Jan 24; 43(1):68-72. PubMed ID: 24139880 [Abstract] [Full Text] [Related]